"Cytosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pyrimidine base that is a fundamental unit of nucleic acids.
| Descriptor ID |
D003596
|
| MeSH Number(s) |
D03.383.742.698.421
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cytosine".
Below are MeSH descriptors whose meaning is more specific than "Cytosine".
This graph shows the total number of publications written about "Cytosine" by people in this website by year, and whether "Cytosine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytosine" by people in Profiles.
-
Mortality in Women across the FMR1 CGG Repeat Range: The Neuroprotective Effect of Higher Education. Cells. 2023 08 24; 12(17).
-
PETCH-DB: a Portal for?Exploring Tissue-specific and?Complex disease-associated 5-Hydroxymethylcytosines. Database (Oxford). 2023 06 10; 2023.
-
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer. 2021 12 01; 127(23):4421-4431.
-
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. Lancet Oncol. 2012 Nov; 13(11):1096-104.
-
5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 2011 Dec 15; 71(24):7360-5.
-
Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010 Oct; 23(4):689-712.
-
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol. 2004 May; 65(5):403-9.